Additionally, the percentage of CD4+FOXP3+ Tregs in tumor tissues (Figure 6D) exhibited a significant positive association with L1CAM and CCL22 in patients with ESCC (Figure 6E and 6F). This evidence concerns the gene FOXP3 and neoplasm.